Tobramycin 40 MG/ML Injectable Solution — RxCUI 597823
RxNorm drug concept · Semantic clinical drug
RxCUI 597823
Semantic clinical drug · SCD
● Current RxNorm concept 19 FDA products
24 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI597823
Official nameTobramycin 40 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astobramycin (as tobramycin sulfate) 40 MG/ML Injectable Solution
FDA products mapped19
Package NDCs mapped24
Reported Medicaid activity (SDUD)6,028 prescriptions · 29 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Tobramycin Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats serious bacterial infections, such as bloodstream, lung, brain and spinal cord (meningitis), abdominal, skin, bone and complicated urinary tract infections. It only works...
- A nurse or other healthcare professional gives it as a shot in the muscle or through an IV, usually a few times a day. Most courses last about 7 to 10 days. You will have blood tes...
- Pain where the shot is given, nausea, headache, fever or rash can happen. Tell your team right away about ringing in the ears, hearing loss, dizziness, spinning feelings, less urin...
- Yes. Tell your team about other drugs that can harm the kidneys or ears, water pills, and any muscle relaxants used in surgery. Combining them raises the risk of serious problems....
🕸️ Concept Web — How Tobramycin 40 MG/ML Injectable Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Tobramycin 40 MG/ML Injectable Solution
RxCUI 597823 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Tobramycin
10627IN
-
Tobramycin
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Tobramycin Injectable Solution
374147SCDF -
Tobramycin Injectable Product
1157109SCDG -
Injectable Solution
316949DF -
Injectable Product
1151126DFG
-
Tobramycin Injectable Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Tobramycin 40 MG/ML
328622SCDC
-
Tobramycin 40 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Tobramycin 40 MG/ML
SCDC · 328622 -
Tobramycin Injectable Solution
SCDF · 374147 -
Tobramycin Injectable Product
SCDG · 1157109
📦 FDA Products & Package NDCs
19 products · 24 package NDCs
24 package NDCs map to RxCUI 597823 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00409-3578-01 | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VI... | TOBRAMYCIN | Hospira, Inc. | 2005-05-05 |
| 36000-0242-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1... | Tobramycin | Baxter Healthcare Corporation | 2016-07-15 |
| 36000-0244-25 | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL... | Tobramycin | Baxter Healthcare Corporation | 2016-07-15 |
| 39822-0412-01 | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL | Tobramycin | XGen Pharmaceuticals DJB, Inc. | 2001-08-17 |
| 39822-0412-06 | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL | Tobramycin | XGen Pharmaceuticals DJB, Inc. | 2001-08-17 |
| 55150-0470-06 | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) /... | TOBRAMYCIN | Eugia US LLC | 2023-06-21 |
| 63323-0303-51 | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30... | Tobramycin | Fresenius Kabi USA, LLC | 2005-11-23 |
| 63323-0303-55 | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30... | Tobramycin | Fresenius Kabi USA, LLC | 2005-11-23 |
| 63323-0305-02 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-305-02) / 2 mL in 1 VI... | Tobramycin | Fresenius Kabi USA, LLC | 2004-11-30 |
| 63323-0306-02 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VI... | Tobramycin | Fresenius Kabi USA, LLC | 2005-11-23 |
| 63323-0306-30 | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 V... | Tobramycin | Fresenius Kabi USA, LLC | 2005-11-23 |
| 67457-0428-30 | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457... | Tobramycin | Mylan Institutional LLC | 2014-02-19 |
| 67457-0473-22 | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-... | Tobramycin | Mylan Institutional LLC | 2014-08-19 |
| 68083-0241-01 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) /... | Tobramycin | Gland Pharma Limited | 2021-02-09 |
| 68083-0253-25 | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-253-25) / 2 mL in 1... | Tobramycin | Gland Pharma Limited | 2021-02-11 |
| 68083-0254-25 | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1... | Tobramycin | Gland Pharma Limited | 2021-02-11 |
| 68083-0312-06 | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) /... | Tobramycin | Gland Pharma Limited | 2021-05-18 |
| 70436-0110-36 | 30 mL in 1 VIAL (70436-110-36) | tobramycin | Slate Run Pharmaceuticals, LLC | 2023-02-01 |
| 70436-0110-56 | 180 mL in 1 CARTON (70436-110-56) | tobramycin | Slate Run Pharmaceuticals, LLC | 2023-02-01 |
| 70436-0110-80 | 30 mL in 1 CARTON (70436-110-80) | tobramycin | Slate Run Pharmaceuticals, LLC | 2023-12-01 |
| 70700-0173-22 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) /... | Tobramycin | Xiromed LLC | 2021-07-12 |
| 70700-0173-86 | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-86) /... | Tobramycin | Xiromed LLC | 2023-01-20 |
| 72266-0163-06 | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) /... | Tobramycin | Fosun Pharma USA Inc | 2021-08-11 |
| 72603-0160-06 | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) /... | Tobramycin | Northstar Rx LLC | 2024-04-01 |
Observed labelers:
Fresenius Kabi USA, LLC (5) ·
Gland Pharma Limited (4) ·
Slate Run Pharmaceuticals, LLC (3) ·
Baxter Healthcare Corporation (2) ·
Mylan Institutional LLC (2) ·
XGen Pharmaceuticals DJB, Inc. (2)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3260 | Tobramycin sulfate injection | 19 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.